Papillary renal cell carcinoma – case report of a patient with disseminated disease treated with pazopanib with several years of survival against reviewing current literature
Journal Title: OncoReview - Year 2016, Vol 6, Issue 2
Abstract
Papillary renal cell carcinoma is the second most common histological type of renal cell carcinoma with distinct cytogenetics, histology and prognosis. It exhibits significantly poorer response to molecular targeted therapies, which are about the progress in clear cell carcinoma. We present an overview of the treatment trials and report a casuistic case of metastatic disease controlled for several years with pazopanib.
Authors and Affiliations
Agnieszka Buraczewska, Joanna Kardas
Keywords
Related Articles
- EP ID EP78742
- DOI 10.5604/20828691.1207967
- Views 163
- Downloads 0
Terapie celowane w nowotworach neuroendokrynnych
Leczeniem z wyboru nowotworów neuroendokrynnych układu pokarmowego jest leczenie operacyjne, a jego zakres zależy od stopnia zaawansowania nowotworu. W przypadku choroby zaawansowanej stosowane są metody leczenia zachowa...
IgM multiple myeloma: diagnostic difficulties and results of bortezomib treatment – case report
The IgM paraprotein secretion is most frequently associated with Waldenström’s macroglobulinemia. In very rare cases it may also occur in multiple myeloma. The diagnostic and therapeutic process of a 84 year old male suf...
Dystres i depresja u chorych na nowotwory - diagnostyka i leczenie
Choroba nowotworowa burzy dotychczasowy porządek wewnętrzny i zewnętrzny pacjenta, który wcześniej nie przeżywał takiej sytuacji. Najczęściej odczuwanymi negatywnymi emocjami w sytuacji diagnozy onkologicznej są: lęk, pr...
Depression in patients with cancer. Diagnosis and treatment in clinical practice
Comorbidity between depression and cancer is a common condition. It depends on many variables such as cancer location or phase of the illness, but as a rule this situation should not be neglected. The reasons for providi...
Bone marrow transplantation – how can we maximize cardiac status?